CCL2 and breast cancer: Williams et al. have recently discovered increased levels of pro-inflammatory molecules (in particular, tumor necrosis factor-alpha, monocyte chemotactic protein-1) in the blood of patients with BC after chemotherapy, and demonstrated a link to visual memory impairment [64], while other researchers have found significantly increased concentrations of interleukins during therapy [65].